CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹92 Cr | ₹247 Cr | ₹520 Cr | ₹824 Cr | ₹1,756 Cr |
What is the latest Total Debt ratio of CIPLA ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹92 Cr |
| Mar2024 | ₹247 Cr |
| Mar2023 | ₹520 Cr |
| Mar2022 | ₹824 Cr |
| Mar2021 | ₹1,756 Cr |
How is Total Debt of CIPLA Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹92 Cr | -62.72 | |
| Mar2024 | ₹247 Cr | -52.53 | |
| Mar2023 | ₹520 Cr | -36.86 | |
| Mar2022 | ₹824 Cr | -53.06 | |
| Mar2021 | ₹1,756 Cr | - | |
Compare Total Debt of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹121,178.1 Cr | -0.3% | -1.1% | -0.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹412,782.0 Cr | -1% | -4.9% | -7.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹168,376.0 Cr | -1.3% | -1.2% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹130,225.0 Cr | 0.2% | 2.8% | 12.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹104,629.0 Cr | -1.2% | -1.8% | -7.7% | Stock Analytics | |
| MANKIND PHARMA | ₹89,293.9 Cr | -1.3% | -2.4% | -23.1% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | -0.3% |
-1.1% |
-0.6% |
| SENSEX | -0.3% |
-0.5% |
8.3% |
You may also like the below Video Courses